Unveiling FADS3 as a novel prognostic biomarker for tumor immunity in clear cell renal cell carcinoma through comprehensive RNA and single-cell sequencing

Asian J Surg. 2024 Nov 27:S1015-9584(24)02612-5. doi: 10.1016/j.asjsur.2024.11.010. Online ahead of print.

Authors

Zekun Xin¹, Lijun Dong¹, Guojun Chen², Yeshan Li³

Affiliations

¹ Department of Urology, Hebei Petro China Central Hospital, Langfang, China.
² Department of Urology, Hebei Petro China Central Hospital, Langfang, China. Electronic address: 462859451@qq.com.
³ Department of Urology, Hebei Petro China Central Hospital, Langfang, China. Electronic address: xshbcxf@126.com.

PMID: 39609202
DOI: 10.1016/j.asjsur.2024.11.010

No abstract available

Keywords: Biomarker; FADS3; Tumor microenvironment; ccRCC.

Publication types

Letter